TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Paras Biopharmaceuticals Finland Oy
Closing information (x1000 DKK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
149
|
463 | |
| Financial expenses |
126
|
37
|
7 |
| Earnings before taxes |
-6,862
|
-3,142
|
-2,070 |
| Total assets |
22,444
|
4,022
|
1,109 |
| Current assets |
15,136
|
582
|
164 |
| Current liabilities |
3,591
|
2,582
|
1,794 |
| Equity capital |
14,965
|
276
|
-960 |
| - share capital |
22
|
1,186
|
22 |
| Employees (average) | 15 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
66.7%
|
6.9%
|
-86.6% |
| Turnover per employee | 10 | ||
| Profit as a percentage of turnover |
-4605.4%
|
-678.6% | |
| Return on assets (ROA) |
-30.0%
|
-77.2%
|
-186.0% |
| Current ratio |
421.5%
|
22.5%
|
9.1% |
| Return on equity (ROE) |
-45.9%
|
-1138.4%
|
215.6% |
| Change turnover | -312 | ||
| Change turnover % | -68% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.